FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034128071> ?p ?o ?g. }

• W2034128071 endingPage "4379" @default.
• W2034128071 startingPage "4373" @default.
• W2034128071 abstract "Steroid-resistant rejection (SRR) results in significant morbidity and mortality from the adverse effects of rescue therapy and in graft loss from chronic rejection. In our knowledge, the efficacy and safety of anti-interleukin (IL) 2r antibodies (daclizumab and basiliximab) for the treatment of SRR in adult liver transplantation has not previously been evaluated.Twenty-five patients received either daclizumab or basiliximab as rescue therapy for SRR. Outcome and biochemical parameters were recorded before and after treatment with an anti-IL-2r antibody.The median time from transplantation to SRR was 25 days. Secondary immunosuppression included mycophenolate mofetil in 18 patients. Twelve patients (48%) had complete resolution of SRR. Aspartate transaminase levels normalized at a median of 37 days (range, 1-168 days). In 13 patients (52%) progressive hepatic dysfunction developed. Four of these patients received another transplant, and 6 patients had chronic rejection. Three patients died with graft failure. Of 16 patients with acute cellular rejection, 12 (75%) had resolution, 2 had chronic rejection, 1 required a repeat transplantation, and 1 died with graft failure. In contrast, all 9 patients with established chronic rejection in their pretreatment biopsy continued to have significant graft dysfunction, with 4 having persistent chronic graft dysfunction, 3 requiring repeat transplantation, and 2 dying with graft failure.Twelve (48%) of 25 patients who received an anti-IL-2r antibody because of SRR were successfully treated. All successfully treated patients had ongoing acute cellular rejection at liver biopsy (75%), whereas patients with histologic evidence of chronic rejection responded poorly." @default.
• W2034128071 created "2016-06-24" @default.
• W2034128071 creator A5005760414 @default.
• W2034128071 creator A5013018249 @default.
• W2034128071 creator A5014226773 @default.
• W2034128071 creator A5018499823 @default.
• W2034128071 creator A5048592898 @default.
• W2034128071 creator A5053928057 @default.
• W2034128071 creator A5057399202 @default.
• W2034128071 creator A5064600273 @default.
• W2034128071 creator A5069788836 @default.
• W2034128071 creator A5090511903 @default.
• W2034128071 date "2005-12-01" @default.
• W2034128071 modified "2023-10-16" @default.
• W2034128071 title "Anti-Interleukin 2 Receptor Antibodies and Mycophenolate Mofetil for Treatment of Steroid-Resistant Rejection in Adult Liver Transplantation" @default.
• W2034128071 cites W1974661501 @default.
• W2034128071 cites W1975024520 @default.
• W2034128071 cites W1976164712 @default.
• W2034128071 cites W1984028098 @default.
• W2034128071 cites W1989170436 @default.
• W2034128071 cites W1992649802 @default.
• W2034128071 cites W1993051112 @default.
• W2034128071 cites W1997331942 @default.
• W2034128071 cites W2000748385 @default.
• W2034128071 cites W2005750835 @default.
• W2034128071 cites W2009867933 @default.
• W2034128071 cites W2018422137 @default.
• W2034128071 cites W2021142445 @default.
• W2034128071 cites W2027202524 @default.
• W2034128071 cites W2029452063 @default.
• W2034128071 cites W2030553138 @default.
• W2034128071 cites W2032151689 @default.
• W2034128071 cites W2045462940 @default.
• W2034128071 cites W2052466686 @default.
• W2034128071 cites W2066524237 @default.
• W2034128071 cites W2069308616 @default.
• W2034128071 cites W2070731552 @default.
• W2034128071 cites W2073178544 @default.
• W2034128071 cites W2078514030 @default.
• W2034128071 cites W2089288905 @default.
• W2034128071 cites W2090639386 @default.
• W2034128071 cites W2102250111 @default.
• W2034128071 cites W2105647067 @default.
• W2034128071 cites W2113539002 @default.
• W2034128071 cites W2120205280 @default.
• W2034128071 cites W2129356278 @default.
• W2034128071 cites W2136905810 @default.
• W2034128071 cites W4230996310 @default.
• W2034128071 cites W4250645453 @default.
• W2034128071 cites W2417682397 @default.
• W2034128071 doi "https://doi.org/10.1016/j.transproceed.2005.10.022" @default.
• W2034128071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16387124" @default.
• W2034128071 hasPublicationYear "2005" @default.
• W2034128071 type Work @default.
• W2034128071 sameAs 2034128071 @default.
• W2034128071 citedByCount "29" @default.
• W2034128071 countsByYear W20341280712012 @default.
• W2034128071 countsByYear W20341280712014 @default.
• W2034128071 countsByYear W20341280712015 @default.
• W2034128071 countsByYear W20341280712016 @default.
• W2034128071 countsByYear W20341280712017 @default.
• W2034128071 countsByYear W20341280712020 @default.
• W2034128071 countsByYear W20341280712021 @default.
• W2034128071 countsByYear W20341280712022 @default.
• W2034128071 crossrefType "journal-article" @default.
• W2034128071 hasAuthorship W2034128071A5005760414 @default.
• W2034128071 hasAuthorship W2034128071A5013018249 @default.
• W2034128071 hasAuthorship W2034128071A5014226773 @default.
• W2034128071 hasAuthorship W2034128071A5018499823 @default.
• W2034128071 hasAuthorship W2034128071A5048592898 @default.
• W2034128071 hasAuthorship W2034128071A5053928057 @default.
• W2034128071 hasAuthorship W2034128071A5057399202 @default.
• W2034128071 hasAuthorship W2034128071A5064600273 @default.
• W2034128071 hasAuthorship W2034128071A5069788836 @default.
• W2034128071 hasAuthorship W2034128071A5090511903 @default.
• W2034128071 hasConcept C126322002 @default.
• W2034128071 hasConcept C141071460 @default.
• W2034128071 hasConcept C2779609443 @default.
• W2034128071 hasConcept C2779719350 @default.
• W2034128071 hasConcept C2780252810 @default.
• W2034128071 hasConcept C2781307858 @default.
• W2034128071 hasConcept C2909675724 @default.
• W2034128071 hasConcept C2911091166 @default.
• W2034128071 hasConcept C71924100 @default.
• W2034128071 hasConcept C90924648 @default.
• W2034128071 hasConceptScore W2034128071C126322002 @default.
• W2034128071 hasConceptScore W2034128071C141071460 @default.
• W2034128071 hasConceptScore W2034128071C2779609443 @default.
• W2034128071 hasConceptScore W2034128071C2779719350 @default.
• W2034128071 hasConceptScore W2034128071C2780252810 @default.
• W2034128071 hasConceptScore W2034128071C2781307858 @default.
• W2034128071 hasConceptScore W2034128071C2909675724 @default.
• W2034128071 hasConceptScore W2034128071C2911091166 @default.
• W2034128071 hasConceptScore W2034128071C71924100 @default.
• W2034128071 hasConceptScore W2034128071C90924648 @default.
• W2034128071 hasIssue "10" @default.
• W2034128071 hasLocation W20341280711 @default.
• W2034128071 hasLocation W20341280712 @default.

• next